Eric Puro is the CEO of KÄÄPÄ Biotech, the leading functional mushroom company in Europe based out of Finland. He joins us again on the Mycopreneur Podcast to discuss the release of their new white paper titled "Beyond Beta Glucans: Why the Future of Functional Mushrooms Depends on Bioactive Standards" which was released yesterday. Their research posits that the functional mushroom industry must move beyond measuring 'Beta-glucans' and to measuring species-specific bioactive compounds for more more substantiative efficacy and truthful labeling in the multi-billion dollar functional mushroom industry.

We also discuss the growth of the global mushroom industry at large, Eric's unique and proven approach to executive leadership, business culture internationally, and more.

Please rate and review this episode wherever you're listening ( :

Hosted on Acast. See acast.com/privacy for more information.